• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>GlaxoSmithKline PLC

GlaxoSmithKline PLC

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. UPDATE: GlaxoSmithKline Shuts Australian Packaging Site

    UPDATE: GlaxoSmithKline Shuts Australian Packaging Site

  2. GlaxoSmithKline Shuts Australia Packaging Site

    GlaxoSmithKline Shuts Australia Packaging Site

  3. GlaxoSmithKline Shuts Australian Tablet-Packing Site

    GlaxoSmithKline Shuts Australian Tablet-Packing Site

  4. Research and Markets: Analyzing the Chemical Industry in the UK 2013

    Research and Markets: Analyzing the Chemical Industry in the UK 2013

  5. Theravance and Elan Enter Into a $1.0 Billion Royalty Participation Agreement

    Theravance and Elan Enter Into a $1.0 Billion Royalty Participation Agreement

  6. Elan Provides Additional Commentary on Elan/Theravance Royalty Participation Agreement

    Elan Provides Additional Commentary on Elan/Theravance Royalty Participation Agreement

  7. Elan, Theravance Enter Into $1.0 Billion Royalty Participation Pact

    Elan, Theravance Enter Into $1.0 Billion Royalty Participation Pact

  8. Research and Markets: Ion Channel Modulators - Global Strategic Business Report - 2013-2018

    Research and Markets: Ion Channel Modulators - Global Strategic Business Report - 2013-2018

  9. GlaxoSmithKline Files Drug Application for UMEC in US

    GlaxoSmithKline Files Drug Application for UMEC in US

  10. GlaxoSmithKline PLC GSK Q1 2011 Earnings Call Transcript

    My name is Simon, I'm your operator today. The format of the call will be some opening remarks from Andrew and Simon and (technical difficulty)

12
Upcoming Events
Conferences
Webinars

©2012 Morningstar Advisor. All right reserved.